Literature DB >> 30100778

Diversity of human African trypanosomiasis epidemiological settings requires fine-tuning control strategies to facilitate disease elimination.

P P Simarro1, J R Franco1, A Diarra2, J A Ruiz Postigo3, J Jannin1.   

Abstract

In 2001, the World Health Organization (WHO) established a public-private partnership to fight human African trypanosomiasis (HAT). As a result of this continuous collaboration, and in addition to the coordination with nongovernmental organizations and bilateral cooperation agencies, the number of new cases of HAT annually reported by the WHO has strikingly decreased. In 2012, HAT was included in WHO's roadmap on neglected tropical diseases with a 2020 target date for elimination. Although the prevalence of HAT is decreasing and its elimination is targeted, control approaches must be adapted to the different epidemiological patterns in order to adopt the most adequate strategies to maintain their cost-effectiveness. These strategies must be flexible and dynamic in order to be adapted to the disease progression, as well as to the changes affecting the existing health facilities in transmission areas, including their accessibility, their capabilities, and their involvement in the elimination process. Considering the different patterns of transmission (Trypanosoma brucei (T.b.) rhodesiense HAT) and transmission intensity (T.b. gambiense HAT), different settings have been defined. In the case of T.b. rhodesiense, this form exists primarily where wild animals are the main parasite reservoir, and where the main parasite reservoir is cattle. In T.b. gambiense, this form exists in areas with high intensity transmission, areas with moderate intensity transmission, and areas with low intensity transmission. Criteria and indicators must be established to monitor and evaluate the actions implemented toward the elimination of HAT.

Entities:  

Keywords:  HAT; T.b. gambiense; T.b. rhodesiense; disease elimination; human African trypanosomiasis; sleeping sickness

Year:  2013        PMID: 30100778      PMCID: PMC6067614          DOI: 10.2147/RRTM.S40157

Source DB:  PubMed          Journal:  Res Rep Trop Med        ISSN: 1179-7282


  15 in total

1.  Human African trypanosomiasis (sleeping sickness): epidemiological update.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2006-02-24

2.  Public-private partnership works to stamp out sleeping sickness in Uganda.

Authors:  John D Kabasa
Journal:  Trends Parasitol       Date:  2007-03-27

3.  The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases.

Authors:  Pere P Simarro; Giuliano Cecchi; Massimo Paone; José R Franco; Abdoulaye Diarra; José A Ruiz; Eric M Fèvre; Fabrice Courtin; Raffaele C Mattioli; Jean G Jannin
Journal:  Int J Health Geogr       Date:  2010-11-01       Impact factor: 3.918

Review 4.  Human African trypanosomiasis in non-endemic countries (2000-2010).

Authors:  Pere P Simarro; José R Franco; Giuliano Cecchi; Massimo Paone; Abdoulaye Diarra; José A Ruiz Postigo; Jean G Jannin
Journal:  J Travel Med       Date:  2011-12-08       Impact factor: 8.490

5.  Epidemiological studies on the animal reservoir of Gambiense sleeping sickness. Part III. Characterization of trypanozoon stocks by isoenzymes and sensitivity to human serum.

Authors:  D Mehlitz; U Zillmann; C M Scott; D G Godfrey
Journal:  Tropenmed Parasitol       Date:  1982-06

6.  Estimating and mapping the population at risk of sleeping sickness.

Authors:  Pere P Simarro; Giuliano Cecchi; José R Franco; Massimo Paone; Abdoulaye Diarra; José Antonio Ruiz-Postigo; Eric M Fèvre; Raffaele C Mattioli; Jean G Jannin
Journal:  PLoS Negl Trop Dis       Date:  2012-10-25

7.  The human African trypanosomiasis control and surveillance programme of the World Health Organization 2000-2009: the way forward.

Authors:  Pere P Simarro; Abdoulaye Diarra; Jose A Ruiz Postigo; José R Franco; Jean G Jannin
Journal:  PLoS Negl Trop Dis       Date:  2011-02-22

8.  Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.

Authors:  Vincent Jamonneau; Hamidou Ilboudo; Jacques Kaboré; Dramane Kaba; Mathurin Koffi; Philippe Solano; André Garcia; David Courtin; Claude Laveissière; Kouakou Lingue; Philippe Büscher; Bruno Bucheton
Journal:  PLoS Negl Trop Dis       Date:  2012-06-12

Review 9.  Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic?

Authors:  José A Ruiz-Postigo; José R Franco; Mounir Lado; Pere P Simarro
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

10.  Risk for human African trypanosomiasis, Central Africa, 2000-2009.

Authors:  Pere P Simarro; Giuliano Cecchi; José R Franco; Massimo Paone; Eric M Fèvre; Abdoulaye Diarra; José Antonio Ruiz Postigo; Raffaele C Mattioli; Jean G Jannin
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

View more
  16 in total

1.  Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study.

Authors:  Sylvie Bisser; Crispin Lumbala; Etienne Nguertoum; Victor Kande; Laurence Flevaud; Gedeao Vatunga; Marleen Boelaert; Philippe Büscher; Theophile Josenando; Paul R Bessell; Sylvain Biéler; Joseph M Ndung'u
Journal:  PLoS Negl Trop Dis       Date:  2016-04-08

2.  Human African trypanosomiasis in the Democratic Republic of the Congo: disease distribution and risk.

Authors:  Crispin Lumbala; Pere P Simarro; Giuliano Cecchi; Massimo Paone; José R Franco; Victor Kande Betu Ku Mesu; Jacquies Makabuza; Abdoulaye Diarra; Shampa Chansy; Gerardo Priotto; Raffaele C Mattioli; Jean G Jannin
Journal:  Int J Health Geogr       Date:  2015-06-06       Impact factor: 3.918

3.  Human African trypanosomiasis research gets a boost: unraveling the tsetse genome.

Authors:  Serap Aksoy; Geoffrey Attardo; Matt Berriman; Alan Christoffels; Mike Lehane; Dan Masiga; Yeya Toure
Journal:  PLoS Negl Trop Dis       Date:  2014-04-24

4.  Human African trypanosomiasis presenting at least 29 years after infection--what can this teach us about the pathogenesis and control of this neglected tropical disease?

Authors:  Darshan Sudarshi; Sarah Lawrence; William Owen Pickrell; Vinay Eligar; Richard Walters; Shumonta Quaderi; Alice Walker; Paul Capewell; Caroline Clucas; Angela Vincent; Francesco Checchi; Annette MacLeod; Michael Brown
Journal:  PLoS Negl Trop Dis       Date:  2014-12-18

5.  De Novo Genome Assembly Shows Genome Wide Similarity between Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.

Authors:  Mark Sistrom; Benjamin Evans; Joshua Benoit; Oliver Balmer; Serap Aksoy; Adalgisa Caccone
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

6.  Discovery of Infection Associated Metabolic Markers in Human African Trypanosomiasis.

Authors:  Sabrina D Lamour; Maria Gomez-Romero; Panagiotis A Vorkas; Vincent P Alibu; Jasmina Saric; Elaine Holmes; Jeremy M Sternberg
Journal:  PLoS Negl Trop Dis       Date:  2015-10-27

7.  Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges.

Authors:  Fabrizio Tediosi; Peter Steinmann; Don de Savigny; Marcel Tanner
Journal:  PLoS Negl Trop Dis       Date:  2013-11-07

Review 8.  Epidemiology of human African trypanosomiasis.

Authors:  Jose R Franco; Pere P Simarro; Abdoulaye Diarra; Jean G Jannin
Journal:  Clin Epidemiol       Date:  2014-08-06       Impact factor: 4.790

9.  Knockdown of Inner Arm Protein IC138 in Trypanosoma brucei Causes Defective Motility and Flagellar Detachment.

Authors:  Corinne S Wilson; Alex J Chang; Rebecca Greene; Sulynn Machado; Matthew W Parsons; Taylor A Takats; Luke J Zambetti; Amy L Springer
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  Tsetse Control and Gambian Sleeping Sickness; Implications for Control Strategy.

Authors:  Inaki Tirados; Johan Esterhuizen; Vanja Kovacic; T N Clement Mangwiro; Glyn A Vale; Ian Hastings; Philippe Solano; Michael J Lehane; Steve J Torr
Journal:  PLoS Negl Trop Dis       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.